Metabolite

KNApSAcK Entry

id C00006094
Name Puerarin / Kakonein
CAS RN 3681-99-0
Standard InChI InChI=1S/C21H20O9/c22-7-14-17(26)18(27)19(28)21(30-14)15-13(24)6-5-11-16(25)12(8-29-20(11)15)9-1-3-10(23)4-2-9/h1-6,8,14,17-19,21-24,26-28H,7H2/t14?,17-,18+,19?,21+/m1/s1
Standard InChI (Main Layer) InChI=1S/C21H20O9/c22-7-14-17(26)18(27)19(28)21(30-14)15-13(24)6-5-11-16(25)12(8-29-20(11)15)9-1-3-10(23)4-2-9/h1-6,8,14,17-19,21-24,26-28H,7H2

Cluster

Phytochemical cluster No. 15
KCF-S cluster No. 22

Link

ChEMBL

By standard InChI
By standard InChI Main Layer CHEMBL486386 CHEMBL1319403 CHEMBL1334785

KEGG

By LinkDB C17057

CTD

By CAS RN C033607

Human Protein / Gene in interaction

8 ChEMBL Protein in interactions

accession description class description compound assay ID (# of activities) # of diseases
(OMIM / KEGG)
P00352 Retinal dehydrogenase 1 Enzyme CHEMBL1319403 CHEMBL1614458 (1)
0 / 0
O75496 Geminin Unclassified protein CHEMBL1334785 CHEMBL2114843 (1)
0 / 0
Q99714 3-hydroxyacyl-CoA dehydrogenase type-2 Enzyme CHEMBL1319403 CHEMBL1613910 (1)
3 / 3
P15428 15-hydroxyprostaglandin dehydrogenase [NAD(+)] Enzyme CHEMBL1319403 CHEMBL1614038 (1)
2 / 2
P03372 Estrogen receptor NR3A1 CHEMBL486386 CHEMBL999948 (1)
1 / 1
Q9UNA4 DNA polymerase iota Enzyme CHEMBL1334785 CHEMBL1794483 (1)
0 / 0
B2RXH2 Lysine-specific demethylase 4E Enzyme CHEMBL1319403 CHEMBL1613914 (1)
0 / 0
Q9NUW8 Tyrosyl-DNA phosphodiesterase 1 Enzyme CHEMBL1319403 CHEMBL1614364 (1)
1 / 1

CTD interaction (86)

compound gene gene name gene description interaction interaction type form reference
pmid
C033607 47 ACLY
ACL
ATPCL
CLATP
ATP citrate lyase (EC:2.3.3.8) puerarin results in increased expression of ACLY mRNA increases expression
mRNA 20706672
C033607 207 AKT1
AKT
CWS6
PKB
PKB-ALPHA
PRKBA
RAC
RAC-ALPHA
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) fulvestrant inhibits the reaction [puerarin results in increased phosphorylation of AKT1 protein] decreases reaction
/ increases phosphorylation
protein 21884717
C033607 207 AKT1
AKT
CWS6
PKB
PKB-ALPHA
PRKBA
RAC
RAC-ALPHA
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) puerarin results in increased phosphorylation of AKT1 protein increases phosphorylation
protein 21884717
C033607 358 AQP1
AQP-CHIP
CHIP28
CO
aquaporin 1 puerarin results in increased expression of AQP1 mRNA increases expression
mRNA 20706672
C033607 360 AQP3
AQP-3
GIL
aquaporin 3 (Gill blood group) puerarin results in increased expression of AQP3 mRNA increases expression
mRNA 20706672
C033607 367 AR
AIS
DHTR
HUMARA
HYSP1
KD
NR3C4
SBMA
SMAX1
TFM
androgen receptor puerarin results in decreased expression of AR mRNA decreases expression
mRNA 20706672
C033607 581 BAX
BCL2L4
BCL2-associated X protein puerarin results in increased expression of BAX protein increases expression
protein 16055262
C033607 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 arsenic trioxide promotes the reaction [puerarin results in decreased expression of BCL2 mRNA] decreases expression
/ increases reaction
mRNA 20416161
C033607 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 puerarin results in decreased expression of BCL2 mRNA decreases expression
mRNA 20416161
C033607 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 puerarin results in decreased expression of BCL2 protein decreases expression
protein 16055262
C033607 332 BIRC5
API4
EPR-1
baculoviral IAP repeat containing 5 arsenic trioxide promotes the reaction [puerarin results in decreased expression of BIRC5 mRNA] decreases expression
/ increases reaction
mRNA 20416161
C033607 332 BIRC5
API4
EPR-1
baculoviral IAP repeat containing 5 puerarin results in decreased expression of BIRC5 mRNA decreases expression
mRNA 20416161
C033607 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) arsenic trioxide promotes the reaction [puerarin results in increased expression of CASP3 protein] increases expression
/ increases reaction
protein 20416161
C033607 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) puerarin results in increased activity of CASP3 protein increases activity
protein 16055262
C033607 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) puerarin results in increased expression of CASP3 protein increases expression
protein 20416161
C033607 841 CASP8
ALPS2B
CAP4
Casp-8
FLICE
MACH
MCH5
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) arsenic trioxide promotes the reaction [puerarin results in increased expression of CASP8 protein] increases expression
/ increases reaction
protein 20416161
C033607 841 CASP8
ALPS2B
CAP4
Casp-8
FLICE
MACH
MCH5
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) puerarin results in increased expression of CASP8 protein increases expression
protein 20416161
C033607 999 CDH1
Arc-1
CD324
CDHE
ECAD
LCAM
UVO
cadherin 1, type 1, E-cadherin (epithelial) puerarin results in increased expression of CDH1 mRNA increases expression
mRNA 20706672
C033607 4512 COX1
COI
MTCO1
MT-CO1
cytochrome c oxidase subunit I puerarin results in increased expression of COX1 mRNA increases expression
mRNA 20706672
C033607 114757 CYGB
HGB
STAP
cytoglobin puerarin results in decreased expression of CYGB mRNA decreases expression
mRNA 20706672
C033607 1830 DSG3
CDHF6
PVA
desmoglein 3 puerarin results in decreased expression of DSG3 mRNA decreases expression
mRNA 20706672
C033607 1950 EGF
HOMG4
URG
epidermal growth factor puerarin results in decreased expression of EGF mRNA decreases expression
mRNA 20706672
C033607 2100 ESR2
ER-BETA
ESR-BETA
ESRB
ESTRB
Erb
NR3A2
estrogen receptor 2 (ER beta) puerarin results in decreased activity of ESR2 protein decreases activity
protein 18937077
C033607 2100 ESR2
ER-BETA
ESR-BETA
ESRB
ESTRB
Erb
NR3A2
estrogen receptor 2 (ER beta) puerarin results in decreased expression of ESR2 mRNA decreases expression
mRNA 20706672
C033607 356 FASLG
ALPS1B
APT1LG1
APTL
CD178
CD95-L
CD95L
FASL
TNFSF6
Fas ligand (TNF superfamily, member 6) arsenic trioxide promotes the reaction [puerarin results in increased expression of FASLG protein] increases expression
/ increases reaction
protein 20416161
C033607 356 FASLG
ALPS1B
APT1LG1
APTL
CD178
CD95-L
CD95L
FASL
TNFSF6
Fas ligand (TNF superfamily, member 6) puerarin results in increased expression of FASLG protein increases expression
protein 20416161
C033607 2200 FBN1
ACMICD
ECTOL1
FBN
GPHYSD2
MASS
MFS1
OCTD
SGS
SSKS
WMS
WMS2
fibrillin 1 puerarin results in decreased expression of FBN1 mRNA decreases expression
mRNA 20706672
C033607 2201 FBN2
CCA
DA9
fibrillin 2 puerarin results in decreased expression of FBN2 mRNA decreases expression
mRNA 20706672
C033607 2246 FGF1
AFGF
ECGF
ECGF-beta
ECGFA
ECGFB
FGF-1
FGF-alpha
FGFA
GLIO703
HBGF-1
HBGF1
fibroblast growth factor 1 (acidic) puerarin results in increased expression of FGF1 mRNA increases expression
mRNA 20706672
C033607 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog puerarin results in increased expression of FOS mRNA increases expression
mRNA 17142977
C033607 3036 HAS1
HAS
hyaluronan synthase 1 (EC:2.4.1.212) puerarin results in decreased expression of HAS1 mRNA decreases expression
mRNA 20706672
C033607 3315 HSPB1
CMT2F
HMN2B
HS.76067
HSP27
HSP28
Hsp25
SRP27
heat shock 27kDa protein 1 puerarin results in increased expression of HSPB1 mRNA increases expression
mRNA 20706672
C033607 3383 ICAM1
BB2
CD54
P3.58
intercellular adhesion molecule 1 puerarin inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA] decreases reaction
/ increases expression
mRNA 21884717
C033607 3383 ICAM1
BB2
CD54
P3.58
intercellular adhesion molecule 1 puerarin inhibits the reaction [TNF protein results in increased expression of ICAM1 protein] decreases reaction
/ increases expression
protein 21884717
C033607 3479 IGF1
IGF-I
IGF1A
IGFI
insulin-like growth factor 1 (somatomedin C) puerarin results in decreased expression of IGF1 mRNA decreases expression
mRNA 20706672
C033607 3552 IL1A
IL-1A
IL1
IL1-ALPHA
IL1F1
interleukin 1, alpha puerarin results in decreased expression of IL1A mRNA decreases expression
mRNA 20706672
C033607 9365 KL
klotho (EC:3.2.1.31) puerarin results in decreased expression of KL mRNA decreases expression
mRNA 20706672
C033607 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) puerarin results in increased phosphorylation of MAPK1 protein increases phosphorylation
protein 21884717
C033607 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) puerarin results in increased phosphorylation of MAPK3 protein increases phosphorylation
protein 21884717
C033607 5599 MAPK8
JNK
JNK-46
JNK1
JNK1A2
JNK21B1/2
PRKM8
SAPK1
SAPK1c
mitogen-activated protein kinase 8 (EC:2.7.11.24) arsenic trioxide promotes the reaction [puerarin results in increased expression of MAPK8 protein] increases expression
/ increases reaction
protein 20416161
C033607 5599 MAPK8
JNK
JNK-46
JNK1
JNK1A2
JNK21B1/2
PRKM8
SAPK1
SAPK1c
mitogen-activated protein kinase 8 (EC:2.7.11.24) puerarin results in increased expression of MAPK8 protein increases expression
protein 20416161
C033607 5599 MAPK8
JNK
JNK-46
JNK1
JNK1A2
JNK21B1/2
PRKM8
SAPK1
SAPK1c
mitogen-activated protein kinase 8 (EC:2.7.11.24) puerarin results in increased phosphorylation of MAPK8 protein increases phosphorylation
protein 21884717
C033607 5601 MAPK9
JNK-55
JNK2
JNK2A
JNK2ALPHA
JNK2B
JNK2BETA
PRKM9
SAPK
SAPK1a
p54a
p54aSAPK
mitogen-activated protein kinase 9 (EC:2.7.11.24) puerarin results in increased phosphorylation of MAPK9 protein increases phosphorylation
protein 21884717
C033607 4157 MC1R
CMM5
MSH-R
SHEP2
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor) puerarin results in decreased expression of MC1R mRNA decreases expression
mRNA 20706672
C033607 4609 MYC
MRTL
MYCC
bHLHe39
c-Myc
v-myc avian myelocytomatosis viral oncogene homolog puerarin results in decreased expression of MYC protein decreases expression
protein 16055262
C033607 4843 NOS2
HEP-NOS
INOS
NOS
NOS2A
nitric oxide synthase 2, inducible (EC:1.14.13.39) puerarin results in decreased expression of NOS2 mRNA decreases expression
mRNA 20706672
C033607 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [puerarin results in increased phosphorylation of NOS3 protein] decreases reaction
/ increases phosphorylation
protein 21884717
C033607 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [[puerarin results in increased phosphorylation of NOS3 protein] which results in increased abundance of Nitric Oxide] decreases reaction
/ increases abundance
/ increases phosphorylation
protein 21884717
C033607 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [puerarin results in increased phosphorylation of NOS3 protein] decreases reaction
/ increases phosphorylation
protein 21884717
C033607 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[puerarin results in increased phosphorylation of NOS3 protein] which results in increased abundance of Nitric Oxide] decreases reaction
/ increases abundance
/ increases phosphorylation
protein 21884717
C033607 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) fulvestrant inhibits the reaction [puerarin results in increased phosphorylation of NOS3 protein] decreases reaction
/ increases phosphorylation
protein 21884717
C033607 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) fulvestrant inhibits the reaction [[puerarin results in increased phosphorylation of NOS3 protein] which results in increased abundance of Nitric Oxide] decreases reaction
/ increases abundance
/ increases phosphorylation
protein 21884717
C033607 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) puerarin results in increased activity of NOS3 protein increases activity
protein 21884717
C033607 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) puerarin results in increased expression of NOS3 mRNA increases expression
mRNA 20706672
C033607 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) puerarin results in increased phosphorylation of NOS3 protein increases phosphorylation
protein 21884717
C033607 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) [puerarin results in increased phosphorylation of NOS3 protein] which results in increased abundance of Nitric Oxide increases abundance
/ increases phosphorylation
protein 21884717
C033607 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) W 7 inhibits the reaction [puerarin results in increased phosphorylation of NOS3 protein] decreases reaction
/ increases phosphorylation
protein 21884717
C033607 4846 NOS3
ECNOS
eNOS
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) W 7 inhibits the reaction [[puerarin results in increased phosphorylation of NOS3 protein] which results in increased abundance of Nitric Oxide] decreases reaction
/ increases abundance
/ increases phosphorylation
protein 21884717
C033607 5241 PGR
NR3C3
PR
progesterone receptor puerarin results in decreased expression of PGR mRNA decreases expression
mRNA 20706672
C033607 5241 PGR
NR3C3
PR
progesterone receptor puerarin results in increased expression of PGR protein increases expression
protein 17142977
C033607 8985 PLOD3
LH3
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 (EC:1.14.11.4) puerarin results in increased expression of PLOD3 mRNA increases expression
mRNA 20706672
C033607 5371 PML
MYL
PP8675
RNF71
TRIM19
promyelocytic leukemia arsenic trioxide promotes the reaction [puerarin results in decreased expression of PML mRNA alternative form] decreases expression
/ increases reaction
mRNA 20416161
C033607 5371 PML
MYL
PP8675
RNF71
TRIM19
promyelocytic leukemia puerarin results in decreased expression of PML mRNA alternative form decreases expression
mRNA 20416161
C033607 5468 PPARG
CIMT1
GLM1
NR1C3
PPARG1
PPARG2
PPARgamma
peroxisome proliferator-activated receptor gamma puerarin results in decreased expression of PPARG mRNA decreases expression
mRNA 20706672
C033607 5731 PTGER1
EP1
prostaglandin E receptor 1 (subtype EP1), 42kDa puerarin results in decreased expression of PTGER1 mRNA decreases expression
mRNA 20706672
C033607 5914 RARA
NR1B1
RAR
retinoic acid receptor, alpha arsenic trioxide promotes the reaction [puerarin results in decreased expression of RARA mRNA alternative form] decreases expression
/ increases reaction
mRNA 20416161
C033607 5914 RARA
NR1B1
RAR
retinoic acid receptor, alpha puerarin results in decreased expression of RARA mRNA alternative form decreases expression
mRNA 20416161
C033607 5914 RARA
NR1B1
RAR
retinoic acid receptor, alpha puerarin results in increased expression of RARA mRNA increases expression
mRNA 20706672
C033607 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A puerarin inhibits the reaction [TNF protein results in increased expression of RELA protein] decreases reaction
/ increases expression
protein 21884717
C033607 6649 SOD3
EC-SOD
superoxide dismutase 3, extracellular (EC:1.15.1.1) puerarin results in decreased expression of SOD3 mRNA decreases expression
mRNA 20706672
C033607 6716 SRD5A2
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2) (EC:1.3.1.22) puerarin results in decreased expression of SRD5A2 mRNA decreases expression
mRNA 20706672
C033607 7015 TERT
CMM9
DKCA2
DKCB4
EST2
PFBMFT1
TCS1
TP2
TRT
hEST2
hTRT
telomerase reverse transcriptase (EC:2.7.7.49) puerarin results in decreased expression of TERT mRNA decreases expression
mRNA 20706672
C033607 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor puerarin inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA] decreases reaction
/ increases expression
protein 21884717
C033607 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor puerarin inhibits the reaction [TNF protein results in increased expression of ICAM1 protein] decreases reaction
/ increases expression
protein 21884717
C033607 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor puerarin inhibits the reaction [TNF protein results in increased expression of RELA protein] decreases reaction
/ increases expression
protein 21884717
C033607 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor puerarin results in decreased activity of TNF protein decreases activity
protein 21884717
C033607 7178 TPT1
HRF
TCTP
p02
p23
tumor protein, translationally-controlled 1 puerarin results in increased expression of TPT1 mRNA increases expression
mRNA 20706672
C033607 7295 TXN
TRDX
TRX
TRX1
thioredoxin puerarin results in increased expression of TXN mRNA increases expression
mRNA 20706672
C033607 7306 TYRP1
CAS2
CATB
GP75
OCA3
TRP
TRP1
TYRP
b-PROTEIN
tyrosinase-related protein 1 (EC:1.14.18.-) puerarin results in decreased expression of TYRP1 mRNA decreases expression
mRNA 20706672
C033607 54658 UGT1A1
BILIQTL1
GNT1
HUG-BR1
UDPGT
UDPGT_1-1
UGT1
UGT1A
UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) UGT1A1 protein results in increased metabolism of puerarin increases metabolic processing
protein 22648071
C033607 54575 UGT1A10
UDPGT
UGT-1J
UGT1-10
UGT1.10
UGT1J
UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) UGT1A10 protein results in increased metabolism of puerarin increases metabolic processing
protein 22648071
C033607 54659 UGT1A3
UDPGT
UDPGT_1-3
UGT-1C
UGT1-03
UGT1.3
UGT1C
UDP glucuronosyltransferase 1 family, polypeptide A3 (EC:2.4.1.17) UGT1A3 protein results in increased metabolism of puerarin increases metabolic processing
protein 22648071
C033607 54578 UGT1A6
GNT1
HLUGP
HLUGP1
UDPGT
UDPGT_1-6
UGT1
UGT1A6S
UGT1F
UDP glucuronosyltransferase 1 family, polypeptide A6 (EC:2.4.1.17) UGT1A6 protein results in increased metabolism of puerarin increases metabolic processing
protein 22648071
C033607 54577 UGT1A7
UDPGT
UDPGT_1-7
UGT-1G
UGT1-07
UGT1.7
UGT1G
UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) UGT1A7 protein results in increased metabolism of puerarin increases metabolic processing
protein 22648071
C033607 54576 UGT1A8
UDPGT
UDPGT_1-8
UGT-1H
UGT1-08
UGT1.8
UGT1A8S
UGT1H
UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) UGT1A8 protein results in increased metabolism of puerarin increases metabolic processing
protein 22648071
C033607 54600 UGT1A9
HLUGP4
LUGP4
UDPGT
UDPGT_1-9
UGT-1I
UGT1-09
UGT1-9
UGT1.9
UGT1AI
UGT1I
UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) UGT1A9 protein results in increased metabolism of puerarin increases metabolic processing
protein 22648071

Related Disease

Diseases related to proteins in ChEMBL interactions

OMIM (7)

OMIM preferred title UniProt
#300438 17-beta-hydroxysteroid dehydrogenase x deficiency Q99714
#119900 Digital clubbing, isolated congenital P15428
#615363 Estrogen resistance; estrr P03372
#259100 Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 P15428
#300705 Mental retardation, x-linked 17; mrx17 Q99714
#300220 Mental retardation, x-linked, syndromic 10; mrxs10 Q99714
#607250 Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 Q9NUW8

KEGG DISEASE (7)

KEGG disease name UniProt
H00026 Endometrial Cancer P03372 (marker)
H00457 Primary hypertrophic osteoarthropathy (PHO) P15428 (related)
H01246 Isolated congenital nail clubbing (ICNC) P15428 (related)
H00480 Non-syndromic X-linked mental retardation Q99714 (related)
H00658 Syndromic X-linked mental retardation Q99714 (related)
H00925 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency Q99714 (related)
H00063 Spinocerebellar ataxia (SCA) Q9NUW8 (related)

Diseases related to CTD interactions

12 disease from interactions of metabolites

MeSH disease OMIM compound disease name evidence type reference
pmid
D019973 C033607 Alcohol-Related Disorders therapeutic
17887948
D001161 C033607 Arteriosclerosis therapeutic
22648071
D002545 C033607 Brain Ischemia therapeutic
16041641
22648071
D003920 C033607 Diabetes Mellitus therapeutic
22648071
D003928 C033607 Diabetic Nephropathies therapeutic
18763636
19761151
D056486 C033607 Drug-Induced Liver Injury therapeutic
22001170
D006461 C033607 Hemolysis marker/mechanism
21453687
D006949 C033607 Hyperlipidemias therapeutic
22001170
D006973 C033607 Hypertension therapeutic
22648071
D007249 C033607 Inflammation therapeutic
23146695
D008103 C033607 Liver Cirrhosis therapeutic
16426832
23146695
D017202 C033607 Myocardial Ischemia therapeutic
22648071